Collector
New Weight-Loss Pill Foundayo Could Expand Access for Millions of Americans | Collector
New Weight-Loss Pill Foundayo Could Expand Access for Millions of Americans
Newsweek

New Weight-Loss Pill Foundayo Could Expand Access for Millions of Americans

FDA approves Eli Lilly’s daily weight‑loss pill Foundayo, a fast‑tracked GLP‑1 drug offering a new option for obesity treatment.

Go to News Site